神经病变治疗药的全球市场2022-2026

全球神经病变治疗药的市场规模在2022年～2026年间，预测将成长到334亿6,000万美元，在预测期间中预计将以5.44％的年复合成长率成长。

新药的认证，联盟·共同研究，生活方式的变化，推动了该市场的成长。

本报告提供全球神经病变治疗药市场相关调查分析，网罗整体分析，市场规模与预测，趋势，成长促进因素，课题，及约25家供应商的供应商分析。

目录

第1章 摘要整理

• 市场概要

第2章 市场形势

• 市场生态系统

第3章 市场规模

• 市场定义
• 市场区隔分析
• 市场规模(2021年)
• 市场预测:2021年～2026年的预测

第4章 波特的五力分析

• 五力的摘要
• 买方议价能力
• 供给企业谈判力
• 新加入厂商业者的威胁
• 替代品的威胁
• 对手的威胁
• 市场情况

第5章 各用途的市场区隔

• 市场区隔
• 各用途的比较
• 中枢神经系统(CNS):市场规模与预测(2021年～2026年)
• 末梢神经系统(PNS):市场规模与预测(2021年～2026年)
• 各用途的市场机会

第6章 客户形势

• 客户形势概要

第7章 各地区的形势

• 各地区的市场区隔
• 各地区的比较
• 北美:市场规模与预测(2021年～2026年)
• 欧洲:市场规模与预测(2021年～2026年)
• 亚洲:市场规模与预测(2021年～2026年)
• 其他地区(ROW):市场规模与预测(2021年～2026年)
• 美国:市场规模与预测(2021年～2026年)
• 英国:市场规模与预测(2021年～2026年)
• 中国:市场规模与预测(2021年～2026年)
• 加拿大:市场规模与预测(2021年～2026年)
• 印度:市场规模与预测(2021年～2026年)
• 各地区形势的市场机会

第8章 促进因素·课题·趋势

• 推动市场要素
• 市场课题
• 推动因素与课题的影响
• 市场趋势

第9章 业者情势

• 概要
• 业者情势
• 混乱形势
• 产业的风险

第10章 供应商分析

• 交易厂商
• 供应商的市场定位
• AbbVie Inc.
• Biogen Inc.
• F. Hoffmann La Roche Ltd.
• H Lundbeck AS
• Johnson and Johnson
• Novartis AG
• Pfizer Inc.
• Sanofi
• Takeda Pharmaceutical Co. Ltd.
• Teva Pharmaceutical Industries Ltd.

第11章 附录

Technavio has been monitoring the neurologic disorders therapeutics market and it is poised to grow by $ 33.46 bn during 2022-2026, accelerating at a CAGR of 5.44% during the forecast period. Our report on the neurologic disorders therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the approval of novel drugs, alliances, and collaborations, and changing lifestyles.

The neurologic disorders therapeutics market analysis includes application segment and geographic landscape.

Technavio's neurologic disorders therapeutics market is segmented as below:

By Application

• CNS
• PNS

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the advent of regenerative medicines as one of the prime reasons driving the neurologic disorders therapeutics market growth during the next few years. Also, drug reformulations and advances in the diagnosis of neurodegenerative indications will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the neurologic disorders therapeutics market covers the following areas:

• Neurologic disorders therapeutics market sizing
• Neurologic disorders therapeutics market forecast
• Neurologic disorders therapeutics market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading neurologic disorders therapeutics market vendors that include AbbVie Inc., Acadia Pharmaceuticals Inc., Acorda Therapeutics Inc., Bayer AG, Biogen Inc., Eisai Co. Ltd., F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, H Lundbeck AS, Johnson, and Johnson, Merck KGaA, Mylan NV, Novartis AG, Otsuka Holdings Co. Ltd., Pfizer Inc., Sanofi, Takeda Pharmaceutical Co. Ltd., Teva Pharmaceutical Industries Ltd., UCB SA, and USWM LLC. Also, the neurologic disorders therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary - Chart on Market Overview
• Exhibit 02: Executive Summary - Data Table on Market Overview
• Exhibit 03: Executive Summary - Chart on Global Market Characteristics
• Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
• Exhibit 05: Executive Summary - Chart on Market Segmentation by Application
• Exhibit 06: Executive Summary - Chart on Incremental Growth
• Exhibit 07: Executive Summary - Data Table on Incremental Growth
• Exhibit 08: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 09: Parent market
• Exhibit 10: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 11: Offerings of vendors included in the market definition
• 3.2 Market segment analysis
• Exhibit 12: Market segments
• 3.3 Market size 2021
• 3.4 Market outlook: Forecast for 2021-2026
• Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ billion)
• Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ billion)
• Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
• Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

• 4.1 Five forces summary
• Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
• 4.2 Bargaining power of buyers
• Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
• 4.3 Bargaining power of suppliers
• Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
• 4.4 Threat of new entrants
• Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
• 4.5 Threat of substitutes
• Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
• 4.6 Threat of rivalry
• Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
• 4.7 Market condition
• Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Application

• 5.1 Market segments
• Exhibit 24: Chart on Application - Market share 2021-2026 (%)
• Exhibit 25: Data Table on Application - Market share 2021-2026 (%)
• 5.2 Comparison by Application
• Exhibit 26: Chart on Comparison by Application
• Exhibit 27: Data Table on Comparison by Application
• 5.3 CNS - Market size and forecast 2021-2026
• Exhibit 28: Chart on CNS - Market size and forecast 2021-2026 ($ billion)
• Exhibit 29: Data Table on CNS - Market size and forecast 2021-2026 ($ billion)
• Exhibit 30: Chart on CNS - Year-over-year growth 2021-2026 (%)
• Exhibit 31: Data Table on CNS - Year-over-year growth 2021-2026 (%)
• 5.4 PNS - Market size and forecast 2021-2026
• Exhibit 32: Chart on PNS - Market size and forecast 2021-2026 ($ billion)
• Exhibit 33: Data Table on PNS - Market size and forecast 2021-2026 ($ billion)
• Exhibit 34: Chart on PNS - Year-over-year growth 2021-2026 (%)
• Exhibit 35: Data Table on PNS - Year-over-year growth 2021-2026 (%)
• 5.5 Market opportunity by Application
• Exhibit 36: Market opportunity by Application ($ billion)

6 Customer Landscape

• 6.1 Customer landscape overview
• Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

• 7.1 Geographic segmentation
• Exhibit 38: Chart on Market share By Geographical Landscape 2021-2026 (%)
• Exhibit 39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
• 7.2 Geographic comparison
• Exhibit 40: Chart on Geographic comparison
• Exhibit 41: Data Table on Geographic comparison
• 7.3 North America - Market size and forecast 2021-2026
• Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ billion)
• Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ billion)
• Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
• Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
• 7.4 Europe - Market size and forecast 2021-2026
• Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ billion)
• Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ billion)
• Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
• Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
• 7.5 Asia - Market size and forecast 2021-2026
• Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ billion)
• Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ billion)
• Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
• Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
• 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
• Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ billion)
• Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ billion)
• Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
• Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
• 7.7 US - Market size and forecast 2021-2026
• Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ billion)
• Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ billion)
• Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
• Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)
• 7.8 UK - Market size and forecast 2021-2026
• Exhibit 62: Chart on UK - Market size and forecast 2021-2026 ($ billion)
• Exhibit 63: Data Table on UK - Market size and forecast 2021-2026 ($ billion)
• Exhibit 64: Chart on UK - Year-over-year growth 2021-2026 (%)
• Exhibit 65: Data Table on UK - Year-over-year growth 2021-2026 (%)
• 7.9 China - Market size and forecast 2021-2026
• Exhibit 66: Chart on China - Market size and forecast 2021-2026 ($ billion)
• Exhibit 67: Data Table on China - Market size and forecast 2021-2026 ($ billion)
• Exhibit 68: Chart on China - Year-over-year growth 2021-2026 (%)
• Exhibit 69: Data Table on China - Year-over-year growth 2021-2026 (%)
• 7.10 Canada - Market size and forecast 2021-2026
• Exhibit 70: Chart on Canada - Market size and forecast 2021-2026 ($ billion)
• Exhibit 71: Data Table on Canada - Market size and forecast 2021-2026 ($ billion)
• Exhibit 72: Chart on Canada - Year-over-year growth 2021-2026 (%)
• Exhibit 73: Data Table on Canada - Year-over-year growth 2021-2026 (%)
• 7.11 India - Market size and forecast 2021-2026
• Exhibit 74: Chart on India - Market size and forecast 2021-2026 ($ billion)
• Exhibit 75: Data Table on India - Market size and forecast 2021-2026 ($ billion)
• Exhibit 76: Chart on India - Year-over-year growth 2021-2026 (%)
• Exhibit 77: Data Table on India - Year-over-year growth 2021-2026 (%)
• 7.12 Market opportunity By Geographical Landscape
• Exhibit 78: Market opportunity By Geographical Landscape ($ billion)

8 Drivers, Challenges, and Trends

• 8.1 Market drivers
• 8.2 Market challenges
• 8.3 Impact of drivers and challenges
• Exhibit 79: Impact of drivers and challenges in 2021 and 2026
• 8.4 Market trends

9 Vendor Landscape

• 9.1 Overview
• 9.2 Vendor landscape
• Exhibit 80: Overview on Criticality of inputs and Factors of differentiation
• 9.3 Landscape disruption
• Exhibit 81: Overview on factors of disruption
• 9.4 Industry risks
• Exhibit 82: Impact of key risks on business

10 Vendor Analysis

• 10.1 Vendors covered
• Exhibit 83: Vendors covered
• 10.2 Market positioning of vendors
• Exhibit 84: Matrix on vendor position and classification
• 10.3 AbbVie Inc.
• Exhibit 85: AbbVie Inc. - Overview
• Exhibit 86: AbbVie Inc. - Product / Service
• Exhibit 87: AbbVie Inc. - Key offerings
• 10.4 Biogen Inc.
• Exhibit 88: Biogen Inc. - Overview
• Exhibit 89: Biogen Inc. - Product / Service
• Exhibit 90: Biogen Inc. - Key offerings
• 10.5 F. Hoffmann La Roche Ltd.
• Exhibit 91: F. Hoffmann La Roche Ltd. - Overview
• Exhibit 92: F. Hoffmann La Roche Ltd. - Business segments
• Exhibit 93: F. Hoffmann La Roche Ltd. - Key news
• Exhibit 94: F. Hoffmann La Roche Ltd. - Key offerings
• Exhibit 95: F. Hoffmann La Roche Ltd. - Segment focus
• 10.6 H Lundbeck AS
• Exhibit 96: H Lundbeck AS - Overview
• Exhibit 97: H Lundbeck AS - Product / Service
• Exhibit 98: H Lundbeck AS - Key offerings
• 10.7 Johnson and Johnson
• Exhibit 99: Johnson and Johnson - Overview
• Exhibit 100: Johnson and Johnson - Business segments
• Exhibit 101: Johnson and Johnson - Key news
• Exhibit 102: Johnson and Johnson - Key offerings
• Exhibit 103: Johnson and Johnson - Segment focus
• 10.8 Novartis AG
• Exhibit 104: Novartis AG - Overview
• Exhibit 105: Novartis AG - Business segments
• Exhibit 106: Novartis AG - Key offerings
• Exhibit 107: Novartis AG - Segment focus
• 10.9 Pfizer Inc.
• Exhibit 108: Pfizer Inc. - Overview
• Exhibit 109: Pfizer Inc. - Product / Service
• Exhibit 110: Pfizer Inc. - Key news
• Exhibit 111: Pfizer Inc. - Key offerings
• 10.10 Sanofi
• Exhibit 112: Sanofi - Overview
• Exhibit 113: Sanofi - Business segments
• Exhibit 114: Sanofi - Key news
• Exhibit 115: Sanofi - Key offerings
• Exhibit 116: Sanofi - Segment focus
• 10.11 Takeda Pharmaceutical Co. Ltd.
• Exhibit 117: Takeda Pharmaceutical Co. Ltd. - Overview
• Exhibit 118: Takeda Pharmaceutical Co. Ltd. - Product / Service
• Exhibit 119: Takeda Pharmaceutical Co. Ltd. - Key news
• Exhibit 120: Takeda Pharmaceutical Co. Ltd. - Key offerings
• 10.12 Teva Pharmaceutical Industries Ltd.
• Exhibit 121: Teva Pharmaceutical Industries Ltd. - Overview
• Exhibit 122: Teva Pharmaceutical Industries Ltd. - Business segments
• Exhibit 123: Teva Pharmaceutical Industries Ltd. - Key news
• Exhibit 124: Teva Pharmaceutical Industries Ltd. - Key offerings
• Exhibit 125: Teva Pharmaceutical Industries Ltd. - Segment focus

11 Appendix

• 11.1 Scope of the report
• 11.2 Inclusions and exclusions checklist
• Exhibit 126: Inclusions checklist
• Exhibit 127: Exclusions checklist
• 11.3 Currency conversion rates for US$
• Exhibit 128: Currency conversion rates for US$
• 11.4 Research methodology
• Exhibit 129: Research methodology
• Exhibit 130: Validation techniques employed for market sizing
• Exhibit 131: Information sources
• 11.5 List of abbreviations
• Exhibit 132: List of abbreviations

Exhibits:

• Exhibits1: Executive Summary - Chart on Market Overview
• Exhibits2: Executive Summary - Data Table on Market Overview
• Exhibits3: Executive Summary - Chart on Global Market Characteristics
• Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
• Exhibits5: Executive Summary - Chart on Market Segmentation by Application
• Exhibits6: Executive Summary - Chart on Incremental Growth
• Exhibits7: Executive Summary - Data Table on Incremental Growth
• Exhibits8: Executive Summary - Chart on Vendor Market Positioning
• Exhibits9: Parent market
• Exhibits10: Market Characteristics
• Exhibits11: Offerings of vendors included in the market definition
• Exhibits12: Market segments
• Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ billion)
• Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ billion)
• Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
• Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• Exhibits17: Five forces analysis - Comparison between 2021 and 2026
• Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
• Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
• Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
• Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
• Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
• Exhibits23: Chart on Market condition - Five forces 2021 and 2026
• Exhibits24: Chart on Application - Market share 2021-2026 (%)
• Exhibits25: Data Table on Application - Market share 2021-2026 (%)
• Exhibits26: Chart on Comparison by Application
• Exhibits27: Data Table on Comparison by Application
• Exhibits28: Chart on CNS - Market size and forecast 2021-2026 ($ billion)
• Exhibits29: Data Table on CNS - Market size and forecast 2021-2026 ($ billion)
• Exhibits30: Chart on CNS - Year-over-year growth 2021-2026 (%)
• Exhibits31: Data Table on CNS - Year-over-year growth 2021-2026 (%)
• Exhibits32: Chart on PNS - Market size and forecast 2021-2026 ($ billion)
• Exhibits33: Data Table on PNS - Market size and forecast 2021-2026 ($ billion)
• Exhibits34: Chart on PNS - Year-over-year growth 2021-2026 (%)
• Exhibits35: Data Table on PNS - Year-over-year growth 2021-2026 (%)
• Exhibits36: Market opportunity by Application ($ billion)
• Exhibits37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• Exhibits38: Chart on Market share By Geographical Landscape 2021-2026 (%)
• Exhibits39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
• Exhibits40: Chart on Geographic comparison
• Exhibits41: Data Table on Geographic comparison
• Exhibits42: Chart on North America - Market size and forecast 2021-2026 ($ billion)
• Exhibits43: Data Table on North America - Market size and forecast 2021-2026 ($ billion)
• Exhibits44: Chart on North America - Year-over-year growth 2021-2026 (%)
• Exhibits45: Data Table on North America - Year-over-year growth 2021-2026 (%)
• Exhibits46: Chart on Europe - Market size and forecast 2021-2026 ($ billion)
• Exhibits47: Data Table on Europe - Market size and forecast 2021-2026 ($ billion)
• Exhibits48: Chart on Europe - Year-over-year growth 2021-2026 (%)
• Exhibits49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
• Exhibits50: Chart on Asia - Market size and forecast 2021-2026 ($ billion)
• Exhibits51: Data Table on Asia - Market size and forecast 2021-2026 ($ billion)
• Exhibits52: Chart on Asia - Year-over-year growth 2021-2026 (%)
• Exhibits53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
• Exhibits54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ billion)
• Exhibits55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ billion)
• Exhibits56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
• Exhibits57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
• Exhibits58: Chart on US - Market size and forecast 2021-2026 ($ billion)
• Exhibits59: Data Table on US - Market size and forecast 2021-2026 ($ billion)
• Exhibits60: Chart on US - Year-over-year growth 2021-2026 (%)
• Exhibits61: Data Table on US - Year-over-year growth 2021-2026 (%)
• Exhibits62: Chart on UK - Market size and forecast 2021-2026 ($ billion)
• Exhibits63: Data Table on UK - Market size and forecast 2021-2026 ($ billion)
• Exhibits64: Chart on UK - Year-over-year growth 2021-2026 (%)
• Exhibits65: Data Table on UK - Year-over-year growth 2021-2026 (%)
• Exhibits66: Chart on China - Market size and forecast 2021-2026 ($ billion)
• Exhibits67: Data Table on China - Market size and forecast 2021-2026 ($ billion)
• Exhibits68: Chart on China - Year-over-year growth 2021-2026 (%)
• Exhibits69: Data Table on China - Year-over-year growth 2021-2026 (%)
• Exhibits70: Chart on Canada - Market size and forecast 2021-2026 ($ billion)
• Exhibits71: Data Table on Canada - Market size and forecast 2021-2026 ($ billion)
• Exhibits72: Chart on Canada - Year-over-year growth 2021-2026 (%)
• Exhibits73: Data Table on Canada - Year-over-year growth 2021-2026 (%)
• Exhibits74: Chart on India - Market size and forecast 2021-2026 ($ billion)
• Exhibits75: Data Table on India - Market size and forecast 2021-2026 ($ billion)
• Exhibits76: Chart on India - Year-over-year growth 2021-2026 (%)
• Exhibits77: Data Table on India - Year-over-year growth 2021-2026 (%)
• Exhibits78: Market opportunity By Geographical Landscape ($ billion)
• Exhibits79: Impact of drivers and challenges in 2021 and 2026
• Exhibits80: Overview on Criticality of inputs and Factors of differentiation
• Exhibits81: Overview on factors of disruption
• Exhibits82: Impact of key risks on business
• Exhibits83: Vendors covered
• Exhibits84: Matrix on vendor position and classification
• Exhibits85: AbbVie Inc. - Overview
• Exhibits86: AbbVie Inc. - Product / Service
• Exhibits87: AbbVie Inc. - Key offerings
• Exhibits88: Biogen Inc. - Overview
• Exhibits89: Biogen Inc. - Product / Service
• Exhibits90: Biogen Inc. - Key offerings
• Exhibits91: F. Hoffmann La Roche Ltd. - Overview
• Exhibits92: F. Hoffmann La Roche Ltd. - Business segments
• Exhibits93: F. Hoffmann La Roche Ltd. - Key news
• Exhibits94: F. Hoffmann La Roche Ltd. - Key offerings
• Exhibits95: F. Hoffmann La Roche Ltd. - Segment focus
• Exhibits96: H Lundbeck AS - Overview
• Exhibits97: H Lundbeck AS - Product / Service
• Exhibits98: H Lundbeck AS - Key offerings
• Exhibits99: Johnson and Johnson - Overview
• Exhibits100: Johnson and Johnson - Business segments
• Exhibits101: Johnson and Johnson - Key news
• Exhibits102: Johnson and Johnson - Key offerings
• Exhibits103: Johnson and Johnson - Segment focus
• Exhibits104: Novartis AG - Overview
• Exhibits105: Novartis AG - Business segments
• Exhibits106: Novartis AG - Key offerings
• Exhibits107: Novartis AG - Segment focus
• Exhibits108: Pfizer Inc. - Overview
• Exhibits109: Pfizer Inc. - Product / Service
• Exhibits110: Pfizer Inc. - Key news
• Exhibits111: Pfizer Inc. - Key offerings
• Exhibits112: Sanofi - Overview
• Exhibits113: Sanofi - Business segments
• Exhibits114: Sanofi - Key news
• Exhibits115: Sanofi - Key offerings
• Exhibits116: Sanofi - Segment focus
• Exhibits117: Takeda Pharmaceutical Co. Ltd. - Overview
• Exhibits118: Takeda Pharmaceutical Co. Ltd. - Product / Service
• Exhibits119: Takeda Pharmaceutical Co. Ltd. - Key news
• Exhibits120: Takeda Pharmaceutical Co. Ltd. - Key offerings
• Exhibits121: Teva Pharmaceutical Industries Ltd. - Overview
• Exhibits122: Teva Pharmaceutical Industries Ltd. - Business segments
• Exhibits123: Teva Pharmaceutical Industries Ltd. - Key news
• Exhibits124: Teva Pharmaceutical Industries Ltd. - Key offerings
• Exhibits125: Teva Pharmaceutical Industries Ltd. - Segment focus
• Exhibits126: Inclusions checklist
• Exhibits127: Exclusions checklist
• Exhibits128: Currency conversion rates for US$
• Exhibits129: Research methodology
• Exhibits130: Validation techniques employed for market sizing
• Exhibits131: Information sources
• Exhibits132: List of abbreviations